PubMed:19759529 / 1152-1361 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":209},"obj":"Sentence"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-entities-OrganismTaxon-PD","denotations":[{"id":"T7","span":{"begin":204,"end":208},"obj":"OrganismTaxon"}],"attributes":[{"id":"A7","pred":"db_id","subj":"T7","obj":"NCBItxid:10095"},{"id":"A8","pred":"db_id","subj":"T7","obj":"NCBItxid:10088"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-entities","denotations":[{"id":"6470","span":{"begin":20,"end":29},"obj":"ChemicalEntity"},{"id":"6471","span":{"begin":57,"end":70},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6472","span":{"begin":102,"end":115},"obj":"GeneOrGeneProduct"},{"id":"6473","span":{"begin":128,"end":134},"obj":"ChemicalEntity"},{"id":"6474","span":{"begin":170,"end":183},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6475","span":{"begin":187,"end":195},"obj":"GeneOrGeneProduct"},{"id":"6476","span":{"begin":204,"end":208},"obj":"OrganismTaxon"}],"attributes":[{"id":"A24","pred":"db_id","subj":"6470","obj":"-1"},{"id":"A25","pred":"db_id","subj":"6471","obj":"MESH:D006948"},{"id":"A26","pred":"db_id","subj":"6472","obj":"NCBIGene:14810"},{"id":"A27","pred":"db_id","subj":"6473","obj":"MESH:D016291"},{"id":"A28","pred":"db_id","subj":"6474","obj":"MESH:D006948"},{"id":"A29","pred":"db_id","subj":"6475","obj":"NCBIGene:14810"},{"id":"A30","pred":"db_id","subj":"6476","obj":"NCBITaxon:10090"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T27","span":{"begin":37,"end":39},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":49,"end":56},"obj":"GeneOrGeneProduct"},{"id":"T29","span":{"begin":71,"end":78},"obj":"GeneOrGeneProduct"},{"id":"T30","span":{"begin":102,"end":115},"obj":"GeneOrGeneProduct"},{"id":"T31","span":{"begin":116,"end":126},"obj":"GeneOrGeneProduct"},{"id":"T32","span":{"begin":187,"end":191},"obj":"GeneOrGeneProduct"},{"id":"T33","span":{"begin":192,"end":195},"obj":"GeneOrGeneProduct"},{"id":"T34","span":{"begin":204,"end":208},"obj":"GeneOrGeneProduct"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T19","span":{"begin":49,"end":56},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":102,"end":115},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":187,"end":191},"obj":"GeneOrGeneProduct"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T4","span":{"begin":57,"end":70},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":170,"end":183},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"originalLabel","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"originalLabel","subj":"T5","obj":"DISEASE"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T11","span":{"begin":102,"end":115},"obj":"GeneOrGeneProduct"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":57,"end":70},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":170,"end":183},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"ID:","subj":"T5","obj":"DISEASE"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":57,"end":70},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":170,"end":183},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"#label","subj":"T5","obj":"DISEASE"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T35","span":{"begin":20,"end":29},"obj":"ChemicalEntity"},{"id":"T36","span":{"begin":102,"end":106},"obj":"ChemicalEntity"},{"id":"T38","span":{"begin":128,"end":134},"obj":"ChemicalEntity"},{"id":"T39","span":{"begin":187,"end":191},"obj":"ChemicalEntity"}],"attributes":[{"id":"A35","pred":"ID:","subj":"T35","obj":"ChemicalEntity"},{"id":"A36","pred":"ID:","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_6121"},{"id":"A37","pred":"ID:","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_31882"},{"id":"A38","pred":"ID:","subj":"T38","obj":"D016291"},{"id":"A39","pred":"ID:","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_6121"},{"id":"A40","pred":"ID:","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_31882"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T5","span":{"begin":204,"end":208},"obj":"OrganismTaxon"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T39","span":{"begin":187,"end":191},"obj":"ChemicalEntity"},{"id":"T38","span":{"begin":128,"end":134},"obj":"ChemicalEntity"},{"id":"T36","span":{"begin":102,"end":106},"obj":"ChemicalEntity"},{"id":"T35","span":{"begin":20,"end":29},"obj":"ChemicalEntity"},{"id":"T87490","span":{"begin":102,"end":115},"obj":"GeneOrGeneProduct"},{"id":"T5047","span":{"begin":170,"end":183},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T79097","span":{"begin":57,"end":70},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T84282","span":{"begin":204,"end":208},"obj":"OrganismTaxon"}],"attributes":[{"id":"A40","pred":"ID:","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_31882"},{"id":"A39","pred":"ID:","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_6121"},{"id":"A38","pred":"ID:","subj":"T38","obj":"D016291"},{"id":"A37","pred":"ID:","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_31882"},{"id":"A36","pred":"ID:","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_6121"},{"id":"A35","pred":"ID:","subj":"T35","obj":"ChemicalEntity"},{"id":"A88834","pred":"#label","subj":"T5047","obj":"DISEASE"},{"id":"A21763","pred":"#label","subj":"T79097","obj":"DISEASE"}],"text":"Results showed that SSR103800 (10-30 mg/kg p.o.) blocked hyperactivity induced by the non-competitive NMDA receptor antagonist, MK-801 and partially reversed spontaneous hyperactivity of NMDA Nr1(neo-/-) mice."}